Pathogenesis of the C3 glomerulopathies and reclassification of MPGN

Recurrent Dense Deposit Disease After Renal Transplantation: An Emerging Role for Complementary Therapies

(2012) J. A. McCaughan et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Causes of Alternative Pathway Dysregulation in Dense Deposit Disease

(2012) Y. Zhang et al.   Clinical Journal of the American Society of Nephrology

Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis

(2012) A. S. Bomback et al.   Clinical Journal of the American Society of Nephrology

Pathology after Eculizumab in Dense Deposit Disease and C3 GN

(2012) L. C. Herlitz et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

C3 glomerulopathy: what's in a name?

(2012) Vivette D. D'Agati et al.   KIDNEY INTERNATIONAL

C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up

(2012) Sanjeev Sethi et al.   KIDNEY INTERNATIONAL

Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies

(2012) Aude Servais et al.   KIDNEY INTERNATIONAL

Eculizumab for the Treatment of Dense-Deposit Disease

(2012) Marina Vivarelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Eculizumab in a Patient with Dense-Deposit Disease

(2012) Erica Daina et al.   NEW ENGLAND JOURNAL OF MEDICINE

Membranoproliferative Glomerulonephritis — A New Look at an Old Entity

(2012) Sanjeev Sethi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Eculizumab and Refractory Membranoproliferative Glomerulonephritis

(2012) Seetha Radhakrishnan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Notice

(2012)   Kidney International Supplements

Pre-emptive Eculizumab and Plasmapheresis for Renal Transplant in Atypical Hemolytic Uremic Syndrome

(2011) C. Nester et al.   Clinical Journal of the American Society of Nephrology

Glomerulonephritis With Isolated C3 Deposits and Monoclonal Gammopathy: A Fortuitous Association?

(2011) F. Bridoux et al.   Clinical Journal of the American Society of Nephrology

Proliferative Glomerulonephritis Secondary to Dysfunction of the Alternative Pathway of Complement

(2011) S. Sethi et al.   Clinical Journal of the American Society of Nephrology

Familial C3 Glomerulopathy Associated with CFHR5 Mutations: Clinical Characteristics of 91 Patients in 16 Pedigrees

(2011) Y. Athanasiou et al.   Clinical Journal of the American Society of Nephrology

Complement and glomerular disease: new insights

(2011) Matthew Pickering et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Alternative complement pathway assessment in patients with atypical HUS

(2011) Lubka T. Roumenina et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion

(2011) Sanjeev Sethi et al.   KIDNEY INTERNATIONAL

Dense deposit disease

(2011) Richard J.H. Smith et al.   MOLECULAR IMMUNOLOGY

Three kidneys, two diseases, one antibody?

(2011) N. Lorcy et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Combined C3b and Factor B Autoantibodies and MPGN Type II

(2011) Qian Chen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Membranoproliferative Glomerulonephritis: Pathogenetic Heterogeneity and Proposal for a New Classification

(2011) Sanjeev Sethi et al.   SEMINARS IN NEPHROLOGY

Dense Deposit Disease Associated With Monoclonal Gammopathy of Undetermined Significance

(2010) Sanjeev Sethi et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome

(2010) Tara K. Maga et al.   HUMAN MUTATION

Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation

(2010) Rubén Martínez-Barricarte et al.   JOURNAL OF CLINICAL INVESTIGATION

Complement Factor H Deficiency Accelerates Development of Lupus Nephritis

(2010) L. Bao et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Recurrent membranoproliferative glomerulonephritis after kidney transplantation

(2010) Elizabeth C. Lorenz et al.   KIDNEY INTERNATIONAL

Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice

(2010) Fadi Fakhouri et al.   KIDNEY INTERNATIONAL

Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis

(2010) Daniel P Gale et al.   LANCET

C3 glomerulopathy: a new classification

(2010) Fadi Fakhouri et al.   Nature Reviews Nephrology

New Treatment Options for Atypical Hemolytic Uremic Syndrome with the Complement Inhibitor Eculizumab

(2010) Özlem Köse et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Complement Inhibitor Eculizumab in Atypical Hemolytic Uremic Syndrome

(2009) C. J. Mache et al.   Clinical Journal of the American Society of Nephrology

Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway

(2009) Sanjeev Sethi et al.   KIDNEY INTERNATIONAL

Autoimmune forms of thrombotic micorangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles

(2009) Christine Skerka et al.   MOLECULAR IMMUNOLOGY

Atypical Hemolytic–Uremic Syndrome

(2009) Marina Noris et al.   NEW ENGLAND JOURNAL OF MEDICINE

Complement Factor H Deficiency and Posttransplantation Glomerulonephritis With Isolated C3 Deposits

(2008) Olivia Boyer et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Dense Deposit Disease: Clinicopathologic Study of 32 Pediatric and Adult Patients

(2008) S. H. Nasr et al.   Clinical Journal of the American Society of Nephrology

C3 deposition glomerulopathy due to a functional Factor H defect

(2008) Sandra Habbig et al.   KIDNEY INTERNATIONAL